Search
results below include Worst Pills, Best Pills Newsletter Articles where your
selected drug is a primary subject of discussion
Incretin-Mimetic Drugs: Do Not Use to Treat Diabetes
[hide all summaries]
(August 2016)
Incretin mimetics, one of the newer classes of diabetes drugs, are widely prescribed in the U.S. Find out why Public Citizen's Health Research Group recommends against using any of these medications.
Liraglutide (SAXENDA) for Weight Loss
[hide all summaries]
(October 2015)
Find out why the recently approved high-dose form of liraglutide, which was originally marketed for treatment of Type 2 diabetes, is not a safe option for managing weight loss
Public Citizen Shines a Light on Off-Label Promotion of Diabetes Drugs
[hide all summaries]
(July 2015)
In a recent complaint to the FDA, we took several makers of diabetes drugs to task for direct-to-consumer ads that promote the drugs for unapproved uses. Find out the names of the drugs targeted in our complaint and the nature of the off-label uses being promoted in the ads.